Healthcare - Biotechnology - NASDAQ - US
$ 36.85
-7.34 %
$ 14.2 B
Market Cap
-6.34
P/E
BALANCE SHEET
18.4 B
ASSETS
4.57 B
LIABILITIES
13.9 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Moderna, Inc.
| Current Assets | 10.3 B |
| Cash & Short-Term Investments | 8.6 B |
| Receivables | 892 M |
| Other Current Assets | 829 M |
| Non-Current Assets | 8.1 B |
| Long-Term Investments | 4.74 B |
| PP&E | 2.66 B |
| Other Non-Current Assets | 700 M |
| Current Liabilities | 3.02 B |
| Accounts Payable | 520 M |
| Short-Term Debt | 88 M |
| Other Current Liabilities | 2.41 B |
| Non-Current Liabilities | 1.56 B |
| Long-Term Debt | 1.22 B |
| Other Non-Current Liabilities | 339 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 2 907.0 | 3 205.0 | 6 848.0 | 2 624.0 | 235.9 | 658.4 | 134.9 | 50.1 |
| Short Term Investments | 5 697.0 | 6 697.0 | 3 879.0 | 1 984.0 | 867.1 | 863.1 | 621.2 | 1 008.1 |
| Receivables | 892.0 | 1 385.0 | 3 175.0 | 1 408.0 | 5.4 | 30.6 | 18.4 | 18.0 |
| Inventory | 202.0 | 949.0 | 1 441.0 | 47.0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 643.0 | 1 364.0 | 607.0 | 252.0 | 20.4 | 11.0 | 8.8 | 11.1 |
| Total Current Assets | 10 325.0 | 13 431.0 | 16 071.0 | 6 298.0 | 1 128.8 | 1 563.0 | 783.2 | 1 087.2 |
| PP&E | 2 658.0 | 2 139.0 | 1 383.0 | 387.0 | 287.9 | 212.0 | 139.0 | 81.2 |
| Intangible Assets | 44.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 52.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 4 743.0 | 8 360.0 | 6 843.0 | 639.0 | 160.0 | 173.0 | 145.9 | 236.6 |
| Other Long Term Assets | 523.0 | 946.0 | 46.0 | 13.0 | 12.7 | 14.2 | 16.4 | 12.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 18 426.0 | 25 858.0 | 24 669.0 | 7 337.0 | 1 589.4 | 1 962.1 | 1 084.5 | 1 417.2 |
| LIABILITIES | ||||||||
| Accounts Payable | 520.0 | 487.0 | 302.0 | 18.0 | 7.1 | 31.2 | 20.7 | 28.2 |
| Short Term Debt | 88.0 | 244.0 | 1 087.0 | 30.0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1 839.0 | 2 154.0 | 1 486.0 | 4 341.0 | 72.7 | 82.5 | 74.0 | 26.9 |
| Total Current Liabilities | 3 015.0 | 4 923.0 | 9 128.0 | 4 389.0 | 143.1 | 222.8 | 191.5 | 162.8 |
| Long Term Debt | 1 218.0 | 1 004.0 | 705.0 | 207.0 | 132.4 | 33.5 | 15.7 | 12.5 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 256.0 | 135.0 | 76.0 | 180.0 | 0.1 | 10.3 | 9.1 | 5.8 |
| Total Liabilities | 4 572.0 | 6 735.0 | 10 524.0 | 4 776.0 | 414.6 | 431.9 | 459.2 | 575.3 |
| EQUITY | ||||||||
| Common Stock | 0 | 0 | 0 | 0 | 34 K | 33 K | 6 K | 6 K |
| Retained Earnings | 13 606.0 | 18 320.0 | 9 958.0 | (2 244.0) | (1 496.5) | (1 006.6) | (621.9) | (365.7) |
| Other Accumulative Comprehensive Income/Loss | (123.0) | (370.0) | (24.0) | 3.0 | 1.8 | (1.3) | (1.2) | (0.4) |
| Total Equity | 13 854.0 | 19 123.0 | 14 145.0 | 2 561.0 | 1 174.8 | 1 530.2 | 625.3 | 841.9 |
| Total Liabilities and Equity | 18 426.0 | 25 858.0 | 24 669.0 | 7 337.0 | 1 589.4 | 1 962.1 | 1 084.5 | 1 417.2 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 382.0 | 394.0 | 403.0 | 381.3 | 330.8 | 81.1 | 376.0 | 376.0 |